Tissue factor and tumor:: Clinical and laboratory aspects

被引:43
作者
Förster, Y
Meye, A
Albrecht, S
Schwenzer, B
机构
[1] Tech Univ Dresden, Inst Biochem, D-01069 Dresden, Germany
[2] Tech Univ Dresden, Dept Urol, D-8027 Dresden, Germany
[3] Tech Univ Dresden, Inst Pathol, D-8027 Dresden, Germany
关键词
tissue factor; tumor; angiogenesis; metastasis; cancer diagnostic and therapy;
D O I
10.1016/j.cca.2005.05.018
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This review summarizes data demonstrating the role of TF in tumor development, metastasis and angiogenesis. TF is a transmembrane protein that is expressed constitutively in some kinds of extravascular cells and transiently in intravascular cells after stimulation with cytokines and growth factors. Originally TF was considered to have a function in the initiation of coagulation. In the last years it became evident that TF plays a role in physiological and pathological processes outside the hemostasis. Up-regulation of TF expression appears to be characteristic of tumor tissue. In a variety of human tumors it was shown by immunohistochemistry, that TF can be expressed in malignant cells as well as in tumor-infiltrating macrophages or endothelial cells. Such abnormal TF expression contributes to the angiogenic process by a shift in the balance between endogenous proangiogenic and antiangiogenic factors. Observations of a significant correlation between elevated TF expression with increased microvessel density and VEGF expression underline the TF involvement in tumor angiogenesis. Furthermore, TF expression influences also metastasis. The effect of TF on metastasis may result from its angiogenic effect, but also from the production of growth factors or adhesion proteins. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:12 / 21
页数:10
相关论文
共 136 条
  • [1] Tissue factor expression and angiogenesis in human prostate carcinoma
    Abdulkadir, SA
    Carvalhal, GF
    Kaleem, Z
    Kisiel, W
    Humphrey, PA
    Catalona, WJ
    Milbrandt, J
    [J]. HUMAN PATHOLOGY, 2000, 31 (04) : 443 - 447
  • [2] Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor
    Abe, K
    Shoji, M
    Chen, J
    Bierhaus, A
    Danave, I
    Micko, C
    Casper, K
    Dillehay, DL
    Nawroth, PP
    Rickles, FR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) : 8663 - 8668
  • [3] URINARY TISSUE FACTOR LEVELS IN PROSTATIC-CARCINOMA - A POTENTIAL MARKER OF METASTATIC SPREAD
    ADAMSON, AS
    FRANCIS, JL
    WITHEROW, RO
    SNELL, ME
    [J]. BRITISH JOURNAL OF UROLOGY, 1993, 71 (05): : 587 - 592
  • [4] URINARY TISSUE FACTOR LEVELS IN TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    ADAMSON, AS
    FRANCIS, JL
    ROATH, OS
    WITHEROW, RO
    SNELL, ME
    [J]. JOURNAL OF UROLOGY, 1992, 148 (02) : 449 - 452
  • [5] AHERN SM, 1993, J BIOL CHEM, V268, P2154
  • [6] Tissue factor expression and prognosis in patients with metastatic prostate cancer
    Akashi, T
    Furuya, Y
    Ohta, S
    Fuse, H
    [J]. UROLOGY, 2003, 62 (06) : 1078 - 1082
  • [7] AN ELISA FOR TISSUE FACTOR USING MONOCLONAL-ANTIBODIES
    ALBRECHT, S
    LUTHER, T
    GROSSMANN, H
    FLOSSEL, C
    KOTZSCH, M
    MULLER, M
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (03) : 263 - 270
  • [8] Albrecht S, 1996, THROMB HAEMOSTASIS, V75, P772
  • [9] PLASMA-CONCENTRATION OF TISSUE FACTOR AND FACTOR-VII IN PATIENTS AFTER ABDOMINAL-SURGERY
    ALBRECHT, S
    MULLER, S
    SIEGERT, G
    LUTHER, T
    MULLER, M
    [J]. THROMBOSIS RESEARCH, 1995, 77 (06) : 557 - 562
  • [10] Tolerance for mutations and chemical modifications in a siRNA
    Amarzguioui, M
    Holen, T
    Babaie, E
    Prydz, H
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (02) : 589 - 595